top of page
이미지 제공: Markus Spiske

Investor Relations

FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEET

(Unit: million won)

Category
2022
2023
2024
2025
Current Assets (Total)
75,655
81,929
97,148
103,712
Non-Current Assets
40,184
35,712
33,250
32,860
Total Assets
115,839
117,641
130,398
136,572
Current Liabilities
7,389
4,821
5,863
4,861
Non-Current Liabilities
358
934
367
75
Total Liabilities
7,747
5,755
6,229
4,936
Capital Stock
4,700
4,700
4,700
4,700
Capital Surplus
12,760
12,760
12,760
12,760
Retained Earnings
114,993
118,217
130,264
137,309
Total Equity
108,092
111,885
124,168
131,637

CONSOLIDATED INCOME STATEMENT

(Unit: million won)

Category
2022
2023
2024
2025
Sales Revenue
50,526
53,787
49,913
53,126
Gross Profit
37,951
38,975
36,060
38,625
Operating Income
6,051
2,195
6,796
7,914
Income Before Tax
10,172
6,880
15,610
11,254
Net Income
8,281
6,304
15,127
10,125

CONSOLIDATED CASH FLOW STATEMENT

(Unit: million won)

Category
2022
2023
2024
2025
Cash Flows from Operating Activities
12,814
7,815
19,267
11,109
Cash Flows from Investing Activities
-6,669
-4,745
-18,737
4,590
Cash Flows from Financing Activities
-7,538
-3,721
-3,741
-3,692
Increase (Decrease) in Cash
-1,402
-574
-3,128
12,382
Beginning Cash Balance
9,860
8,458
7,884
4,757
Ending Cash Balance
8,458
7,884
4,757
17,139

DISCLOSURE

Copyright (c) 2024 Cell Biotech. All rights reserved.

HEADQUARTER

CELL BIOTECH  

Address

50, Aegibong-ro 409beon-gil, Gaegok-ri, Wolgot-myeon, Gimpo-si, Gyeonggi-do, Republic of Korea


Tel

(+82)31-987-6205 

SALES/MARKETING

CELL BIOTECH INTERNATIONAL

Address

3F, Bluecom Tower, Seocho-daero 274, Seocho-gu, Seoul, 06645, Korea

Tel

(+82)-2-2668-6077 

EUROPE OFFICE

CELL BIOTECH INTERNATIONAL A/S

Address

sorgenfrivej 15, 2800 Kongens Lyngby, Denmark

Tel

(+45) 3977-5040

bottom of page